CI Investments Inc
CRL icon

CI Investments Inc’s Charles River Laboratories CRL Stock Holding History

CI Investments Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Buy
+1,188
New +$212K ﹤0.01% 719
2025
Q4 		– Sell
-211
Closed -$33K – 790
2025
Q3 		$33K Buy
211
+24
+13% +$3.81K ﹤0.01% 1089
2025
Q2 		$28K Sell
187
-56,118
-100% -$7.48M ﹤0.01% 1116
2025
Q1 		$8.47M Sell
56,305
-29,938
-35% -$5.02M 0.04% 232
2024
Q4 		$15.9M Sell
86,243
-7,557
-8% -$1.46M 0.06% 194
2024
Q3 		$18.5M Sell
93,800
-23,807
-20% -$4.95M 0.07% 182
2024
Q2 		$24.3M Sell
117,607
-6,179
-5% -$1.4M 0.1% 148
2024
Q1 		$33.5M Sell
123,786
-2,522
-2% -$602K 0.13% 131
2023
Q4 		$29.9M Sell
126,308
-180,379
-59% -$35.5M 0.15% 128
2023
Q3 		$60.1M Buy
306,687
+8,767
+3% +$1.8M 0.34% 74
2023
Q2 		$62.6M Buy
297,920
+8,013
+3% +$1.59M 0.32% 81
2023
Q1 		$58.5M Buy
289,907
+218,461
+306% +$49.5M 0.29% 90
2022
Q4 		$15.6M Buy
71,446
+29,554
+71% +$6.45M 0.08% 191
2022
Q3 		$8.24M Buy
41,892
+41,236
+6,286% +$8.9M 0.04% 250
2022
Q2 		$140K Buy
656
+100
+18% +$24.4K ﹤0.01% 662
2022
Q1 		$158K Buy
556
+550
+9,167% +$170K ﹤0.01% 769
2021
Q4 		$2K Sell
6
-1,385
-100% -$538K ﹤0.01% 1182
2021
Q3 		$574K Buy
+1,391
New +$578K ﹤0.01% 573

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

CI Investments Inc's CRL Position: Q2 2026 in Review

CI Investments Inc opened a new position in Charles River Laboratories (CRL) in Q2 2026: 1,188 shares worth $269K. The stake represents ﹤0.01% of the portfolio and ranks #719 among its holdings. This is a return to the name: CI Investments Inc previously reported a position in CRL as recently as Q3 2025.

CI Investments Inc first reported a position in CRL in Q3 2021 and has held it in 18 quarters since. The position peaked at $62.6M in Q2 2023. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • CI Investments Inc held 1,188 shares of Charles River Laboratories worth $269K as of Q2 2026.
  • Charles River Laboratories was a new CI Investments Inc position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of CI Investments Inc's portfolio in Q2 2026, its #719 holding.
  • CI Investments Inc first reported a position in Charles River Laboratories in Q3 2021 and has held it in 18 quarters since.
  • CI Investments Inc's Charles River Laboratories position peaked at $62.6M in Q2 2023.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.